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Abstract
Assessment of cellular rates of amino acid consumption and release in vitro 
allows the study of cell culture in a time-course experiment without any cell 
damage. Determination of the release of amino acid metabolites that initially 
were not present in the media provides more reliable information about the 
processes of growth and differentiation in comparison with determination of 
amino acid consumption rates. Homoarginine (hArg), a derivative of arginine, is 
generated as the minor product in the reaction catalyzed by L-Arginine: glycine 
amidinotransferase, where L-lysine serves as an acceptor for amidine group 
instead of glycine. Ornithine is another product generated in this reaction from 
arginine. Thus, the goal of the present study was to evaluate the rate of hArg 
and ornithine accumulation in comparison to the rate of consumption of other 
amino acids in the course of C2C12 myoblast differentiation. The release time 
profiles were similar for hArg and ornithine, with the maximum corresponding 
to the second day of differentiation. The shift for hArg at this time point was 
detected with greater reliability (p < 0.002) than for ornithine and other amino 
acids. We suggest that hArg and ornithine could serve as markers to monitor 
the processes of myoblasts growth and differentiation. 
Keywords: amino acids, homoarginine, myogenic differentiation, ornithine. 
Introduction
The consumption of amino acids by cell cultures characterizes their metabolism 
and therefore could be used to assess the development of cell culture. Determi-
nation of amino acid intake is important to have an idea about the assimilation 
processes in the progress of cell development, which will allow optimization or 
creation of new culture media, cell production for cell therapies, in modern bio-
technology, or in basic research (Hong, Wheat, Mazzeo, and Diehl, 2007; Carillo-
Cocom et al., 2015; Salazar, Keusgen, and von Hagen, 2016). Estimation of amino 
acid consumption from cell milieu provides information in a time-course experi-
ment without cell damage or interference in the cell mass area (Carillo-Cocom 
et al., 2015; Salazar, Keusgen, and von Hagen, 2016). The cell culture media con-
tains large excesses of essential and conditionally essential amino acids, thus their 
consumption by cells may be only a small percentage of the total, which means 
that an evaluation of their decrease is not accurate enough. The determination of 
metabolites or derivatives of amino acids that initially were not included in the 
media could provide more reliable information about the growth and differentia-
tion of cell culture. Homoarginine (hArg) is known as an unusual derivative of 
arginine. In animal tissues it is generated additionally to guanidine acetic acid in a 
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reaction catalyzed by L-Arginine: glycine amidinotrans-
ferase [AGAT; EC 2.1.4.1] (März et al., 2010; Drechsler 
et al., 2011; Atzler et al., 2014). Therefore, hArg content 
in culture media could be a marker of cell growth. In hu-
man and animal tissues hArg is formed in the AGAT re-
action, where L-lysine serves as an acceptor of amidine 
group instead of glycine. Ornithine is another product 
which is generated in this reaction from arginine (Da-
vids et al., 2012; Choe et al., 2013). Human AGAT is ex-
pressed in various tissues. It is highly expressed in the 
kidneys and pancreas; with less extension in skeletal 
muscles, the myocardium and the brain (Van Pilsum, 
Stephens, and Taylor, 1972; Cullen et al., 2006).
C2C12  murine myoblasts represent a widespread 
experimental model to study skeletal muscle growth 
and differentiation in vitro (Yaffe and Saxel, 1977). 
Moreover, expression of AGAT was observed in rodent 
muscle tissue during embryogenesis (Braissant et al., 
2005); therefore, this model was chosen for the present 
study. AGAT expression was remarkably reduced in dif-
ferentiated cells in comparison to non-differentiaed cells 
(Braissant et al., 2005; Sandell, Guan, Ingram, and Tilgh-
man, 2003). Examination of hArg accumulation in the 
course of myoblast differentiation into myotubes hasn’t 
been performed yet.
The goal of the present study was to evaluate the rate 
of hArg and ornithine accumulation in comparison with 
rates of consumption of other amino acids in the course 
of C2C12 myoblast differentiation into myotubes. 
Materials and Methods
CULTIVATION OF C2C12 CELLS 
The C2C12  cell line, representing mouse adherent 
myoblasts, was a kind gift from Prof. Thomas Sejer-
sen (Group of myopathy research, Karolinska Insti-
tutet, Stockholm, Sweden). The cells were seeded at 
2×105 cells/well in 6-well plates and cultivated for 72 h 
in 2 ml/well of growth media (GM: DMEM (Invitrogen, 
USA, 41966-29) supplemented with heat-inactivated 
10 % fetal calf serum, 4  mM glutamine, and 1 % pen-
icillin-streptomycin (all from Invitrogen, USA)). The 
cultivation was performed in the incubator at 37 °С, 5 % 
CO2, 99 % humidity. 
MYOGENIC DIFFERENTIATION
C2C12  myogenic differentiation was performed ac-
cording to the protocol developed by Keire (Keire et 
al., 2013). To induce differentiation, the growth media 
was removed, cells were washed once with pre-warmed 
phosphate-buffered saline (PBS), and then 2 ml/well of 
differentiation media (DM: DMEM supplemented with 
2 % horse serum (Gibco, USA), 4  mM glutamine, and 
1 % penicillin-streptomycin) was added. Sampling DM 
for analysis and its complete replacement after wash-
ing with PBS were performed every 48 h (first time after 
72  h of cultivation). Thus, we obtained samples of the 
culture media at differentiation days 0  (induction), 2, 
4, 7, 9, and 11. Samples were immediately frozen and 
stored prior to analysis at -80 °C. Control of myogenic 
differentiation was performed by immunofluorescence 
staining of desmin, myosin heavy chains, myogenin and 
mitofusin. The amino acid composition of samples was 
compared with that of corresponding basal media: GM 
(day 0) or DM (other days). 
SAMPLE PREPARATION
Samples were deproteinized by mixing 100  µl aliquots 
with 175 μl ice-cold methanol acidified with 0.2 % for-
mic acid and containing norvaline as an internal stan-
dard. The tubes were centrifuged at 3000×g and 5 °C for 
20 min after 30 min incubation at -20 oC. The superna-
tant was directly used for amino acid analysis.
AMINO ACID HPLC ANALYSIS
Plasma amino acid profiles were determined by means of 
reversed phase HPLC with the help of Agilent 1100 chro-
matograph involving quaternary pump, autosampler and 
fluorescent detector, using 3.5 µm Zorbax Eclipse AAA 
C18 column (4.6 × 150) mm (Agilent Part No 963400-
902) with corresponding precolumn. Ortho-phthalic al-
dehyde (OPA) of amino acid derivatives was loaded on 
the column following recommendations of the supplier 
Agilent Technologies (Henderson, 2000) in our modi-
fication, which allowed us to determine with sufficient 
accuracy the concentrations of homoarginine and orni-
thine. Briefly, the reaction for preparing ortho-phthalic 
derivatives was performed on-line using the Agilent 
1100 autosampler by mixing 2.5 µl of borate buffer, 0.5 µl 
of o-phthalaldehyde reagent (OPA) and 0.5 µl of the sam-
ple. After 6-times stirring in the seat of the autosampler 
and a 0.1 min delay, fluorescent derivatives of amino ac-
ids were injected in the stream. The elution was carried 
out at 1.5 ml/min and 40 °C in mobile phase gradient by 
mixing solutions: A) 40  mM sodium phosphate buffer, 
pH 7.8, and B) acetonitrile: methanol: water (45:45:10). 
The content of solution B increased from 1.5 % to 10 % 
by min 0.1  and then from 10  to 14 % by min 11, then 
it reached 20 % by min 15, and 60 % by min 26. After 
minutes of flushing by 100 % solution B, the column was 
equilibrated for minutes by starting phase mixture con-
taining 1.5 % of solution B. Fluorescence of the amino 
acid–OPA derivatives was monitored at excitation and 
emission wavelengths of 340  and 450  nm, respectively. 
Amino acid concentrations were expressed per 1 ml of 
plasma using norvaline as an internal standard.
In our modification of the method, the hArg peak 
was eluted with good resolution between the peaks of Ala 
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and Tyr, whereas the ornithine peak was between Ile and 
Leu. The elution of the remaining amino acids was per-
fomed according to Agilent’s protocol (Henderson, 2000). 
In separate experiments, the limit of quantification (LOQ) 
of hArg in plasma samples was defined as LOQ = 0.20 ± 
0.005  µmol/L. The coefficient of analytical variation was 
equal to 3.1 % (n = 10). These analytical characteristics are 
quite close to another HPLC-based method without solid-
phase extraction recently published by Hou et al. in 2015.
IMMUNOFLUORESCENCE
Cells were fixed in 4 % paraformaldehyde for 10 min at 
4°C and then permeabilized with 0.05 % Triton X-100 for 
5 min. Nonspecific binding was blocked by incubation 
of permeabilized cells in 15 % FCS for 30 min. Cells 
were incubated for one hour at room temperature with 
the following primary antibodies: anti-desmin (D33, 
DAKO, Denmark), anti-myosin heavy chain (MAB4470, 
R&D, USA), anti-mitofusin 2 (ab56889, Abcam, USA). 
The secondary antibodies conjugated with Alexa Fluor 
546  (Molecular Probes, USA) were applied for 45 min 
at room temperature. Nuclei were counterstained with 
DAPI (Molecular Probes, USA).
DATA ANALYSIS
To evaluate the release of amino acids (increase) to or 
their consumption (decrease) from the cultivation me-
dia, the concentration of amino acid found in the sample 
was subtracted from the concentration found in the ap-
propriate basal media (GM or DM). The amino acid re-
lease/consumption rates were calculated by multiplying 
the resulting difference to the volume of the incubation 
media and dividing by the number of days of incuba-
tion for the given period of time (2 or 3 days); it was ex-
pressed as nmol/day per 2 × 105 of primary seeded cells. 
Data are expressed as mean + s.e.m. from two indepen-
dent experiments with three technical replicates (n = 6). 
The compliance of data with the normal distribution 
was checked by Shapiro-Wilk’s W test. The significance 
of differences was assessed by Student’s t-test for paired 
data, since all the data were normally distributed. The 
level of significance was set at p < 0.05. Statistical analy-
sis was performed using Statistica 10 software.
Results
Immunocytochemistry confirmed that myotubes 
formed from C2C12  cells expressed proteins typical 
to late stages of muscle differentiation, e.g., sarcomere 
proteins desmin and MyHC (Fig. 1A, E, B, F). Staining 
with anti-mitofusin 2  antibody to visualize mitochon-
dria revealed a patchy staining in myotubes, confirm-
ing the well-developed mitochondrial network forming 
during the myotubes maturation (Fig. 1C, G). Moreover, 
the muscle-specific transcriptional factor myogenin, 
required for the proper differentiation of most myo-
genic precursor cells during myogenesis, was revealed 
(Fig. 1D, H). We did not observe a noticeable deteriora-
tion in cell viability during cell differentiation. 
Cultivation media based on DMEM contains an 
excessive amount of all essential and several nones-
sential (glutamine, serine, glycine, tyrosine, cysteine) 
amino acids. However, the amino acid composition of 
the GM and DM were slightly different, primarily due 
to the different amounts of serum additives and their 
source (10 % FCS in GM and 2 % HS in DM). Nones-
sential amino acids, except for those mentioned above 
which were contained in the media in small amounts, 
and derivatives of arginine, i.e. citrulline, ornithine, and 
Fig.	1.	Immunofluorescence of C2C12 myotubes differentiation. C2C12 myotubes differentiated for 72 hours (A−D) and 7 days (E−H) express 
proteins typical to late stages of muscle differentiation, e.g., (A,E) sarcomere proteins desmin, (B,F) MyHC (myosin heavy chain), (C,G) mitochon-
drial protein mitofusin and (D,H) muscle specific transcriptional factor myogenin. All differentiation markers are shown in red. Nuclei were 
stained with DAPI. Scale bar corresponds to 50μm.
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hArg, were found in the GM at a minimal level, but were 
not detected in the DM. 
The data presented in Fig. 2A and in Table 1 show 
that the derivatives of arginine (hArg, ornithine, and ci-
trulline) were released into the media in the course of 
myotubes development. The time course of the release 
rate were similar for hArg and ornithine, with a maxi-
mum corresponding to the second day of differentiation. 
It should be noted that the shift for hArg at this time 
point was detected with greater reliability (p < 0.002) 
than for ornithine and other amino acids. As early as 
day 4, the release of hArg was significantly reduced 
compared to day 2  and further was maintained at the 
minimal level.
There is a positive correlation between the daily 
production of hArg and ornithine (r = 0.53; p = 0.008), 
but not with the consumption rate of other amino acids, 
including those metabolically related to hArg (Arg, Lys, 
and Gly (Fig. 2B)). Among the essential, the branched-
chain amino acids (Val, Leu, and Ile) were most inten-
sively consumed from the media until day 7 of differen-
tiation, and then their simultaneous release into the me-
Fig.	2.	Rates of the release (positive values) or consumption (negative values) of some amino acids to/from cultivation media during C2C12 dif-
ferentiation. Means (s.e.m.) of six experiments are shown. The significance of differences was estimated using Student’s t-test: * — p<0.05 com-
pared to day 0, # — p<0.05 compared to day 2.
Table	1.	The	range	of	amino	acid	concentration	shift	(µM)	increment	in	(+)	or	consumption	from	(−)	the	cultivation	media	
compared	with	basal	media	composition	
Amino	
acids
Amino	acid	concentration	(µM)	 Amino	acid	shift	(µM)
Growth	
media,	n=3
Differentiation	
media,	n=3
Days	of	differentiation
0 2 4 7 9 11
Arg 412 (12)2 406 (17)2 29 (68)pall>0.05
−63 (25)
p11<0.05
−12 (28) −35 (47) 53 (61) 33 (27)
hArg 1.51 (0.08)1 n.d.3 0.58 (0.25)p2 =0.009
1.85 (0.22)
p4,7,9,11<0.002
0.73 (0.09)
p9,11<0.03
0.40 (0.06)
p9=0.02
0.32 (0.10) 0.33 (0.00)
Cit 13 (0.05)1 1.0 (0.07)1 −4.1 (1.2)p2,4,7,9,11<0.008
3.9 (0.7)
p9,11<0.0001
2.7 (0.5)
p9,11<0.0003
4.6 (1.2)
p9,11<0.007
152 (29) 73 (2.5)
Orn 20 (1.2)1 n.d.3 19 (5.2)pall>0.05
25 (1.2)
p4,9,11<0.02
19 (0.9) 25 (5.0) 18 (2.3) 16 (2.0)
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dia was observed (Fig. 2C). The use of branched-chain 
amino acids in biosynthetic processes was confirmed by 
morphology. The formation of significant amounts of 
myosin heavy chain was observed at 72 h after induc-
tion of differentiation, and by day 7  myosin became 
more aligned, forming myofibrills. We observed an 
unusually high release of most amino acids (especially 
essential amino acids and citrulline) by differentiation 
days 9–11. On differentiation day 9, the concentration 
of essential amino acids exceeded their initial content 
in the differentiation media by approximately 1.3 times 
(Fig. 2C). The time course of non-essential amino acids 
involved in energy metabolism during myogenic dif-
ferentiation of C2C12 myoblasts differed. A high initial 
concentration of Gln (4000 uM) fell by about two times 
after each replacement of the media, including on days 
9 and 11 (Fig. 2D), whereas alanine, which was present-
ed in the differentiation media in minimal amounts, was 
constantly released into the media in high concentration 
throughout the entire experiment. 
Values are given in µM and represent means of six 
experiments; s.e.m. is given in parentheses. Data from 
day 0  corresponding the differentiation induction are 
compared with the content of growth media, while data 
from the others were compared with content of differ-
entiation media. Superscript indexes specify the origi-
nation of AA: 1 ― from serum supplementation only, 
2 ― from both DMEM and supplementation, 3 ― not 
determined. The significance of differences was estimat-
ed using Student’s t-test.
Discussion
Obtained results indicate that the consumption of essen-
tial amino acids found until day 7 of differentiation was 
due to their participation in the synthesis of specific mus-
cle proteins. The peak of amino acid flux from the me-
dia was observed on day 2 of differentiation, which cor-
responded to the immunofluorescent data showing bio-
synthesis of substantial amounts of myosin heavy chain 
(Fig. 1B,F). However, it was tricky to use the consumption 
level of essential amino acids (e.g., branched-chain amino 
acids, see Fig. 2B) for monitoring cell growth, since the 
cultivation media contained a lot of them, and therefore 
their decrease from the baseline level was not drastic. The 
assimilation of certain other amino acids was significant 
throughout the period of observation. For example, the 
glutamine level decreased significantly at day 7 of cell dif-
ferentiation, and the same at days 9–11 was shown, while 
others amino acid intake was not detected. The concen-
tration of alanine increased permanently in the medium, 
starting from the second day of differentiation. This was 
apparently caused primarily by its participation in energy 
metabolism, rather than the expression of new proteins 
in the cell culture, since alanine was mainly synthesized 
in the course of transamination reactions which involved 
pyruvic acid and other amino acids. It should be noted 
that the concentration of pyruvic acid in the media was 
about 1  mM. Thus, the alanine determination was less 
suitable than the determination of glutamine in cell media 
for cellular differentiation monitoring. An increased level 
of amino acid (both essential and nonessential) in the me-
dia could be regarded as a sign of the completion of cellu-
lar differentiation and the activation of programmed cell 
death processes which are typical for highly differentiated 
C2C12 myoblasts (Burattini et al., 2004). In the present 
study, we showed that the release of arginine derivatives 
may be determined with greater reliability than the con-
sumption of starting amino acid from the medium, in-
cluding arginine. The most significant shift in the course 
of C2C12 differentiation was found for hArg compared 
to other arginine derivatives, i.e., ornithine or citrulline 
(Table 1). Observed alterations of hArg level in the media 
could be explained by the fact that hArg is poorly used in 
metabolic pathways and completely released to the me-
dia, unlike ornithine, citrulline, and alanine (Hou et al., 
2016). The relatively high correlation between the profiles 
of hArg and ornithine, but not citrulline, confirms that 
the AGAT reaction could be considered a primary origin 
of hArg.
Conclusion
In the present study, we suggest that hArg and ornithine 
could serve as the most suitable markers for monitoring 
myoblast growth and differentiation compared to other 
amino acids and their derivatives.
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